Your knees ache on the stepmill, the squat rack, or around mile three. You've probably been told to take grams of collagen powder. But one randomized trial tested a dose of just 40 milligrams a day, and the results were striking enough to deserve a close look, along with the caveats.
What Is UC-II, and Why Is 40 mg Not a Typo?
UC-II is a branded form of undenatured type II collagen derived from chicken sternum. Most collagen supplements are hydrolyzed: the protein is broken into small peptides and usually dosed at roughly 5 to 15 grams. UC-II is a different product. The collagen is kept in a less processed ("undenatured") state and given in milligrams, not grams.
The dose gap is easy to see in numbers. A 10 g scoop of hydrolyzed collagen is 10,000 mg. The UC-II dose in this trial was 40 mg, about 250 times smaller. The two products are not interchangeable. UC-II is generally thought to act through a different, immune-related pathway often called oral tolerance, rather than by supplying amino-acid building blocks. That mechanism is a proposed explanation, not something this study tested.
The Study Design: Healthy Lifters, Cranky Knees
The paper, published in the Journal of the International Society of Sports Nutrition (Lugo et al., 2013), was a randomized, double-blind, placebo-controlled trial. That is the right design for a question like this.
- Who: 55 healthy adults with no history of arthritis and no joint pain at rest, but who felt knee discomfort with physical activity.
- Groups: 27 received UC-II and 28 received placebo.
- Dose and duration: 40 mg of UC-II daily for 120 days.
- The test: A standardized stepmill session designed to provoke knee pain.
- What was measured: Knee flexion and extension, time until joint discomfort began, and time to recover from the pain.
These were not arthritis patients. They were active people whose knees complained under load, which describes plenty of lifters and runners.
The Results: Where the Headline Numbers Come From
Two findings stand out.
1. Time to first knee pain roughly doubled. In the UC-II group, participants exercised for about 2.8 minutes before feeling initial discomfort at day 120, compared with 1.4 minutes at baseline (p = 0.019). The placebo group showed no significant change.
2. Knee extension improved. At day 120, average knee extension in the UC-II group was 81.0° versus 74.0° for placebo (p = 0.011), and up from 73.2° at baseline (p = 0.002). The UC-II group was also significantly improved over baseline at day 90 (78.8°, p = 0.045). The placebo group showed no significant change at any point.
There was one more detail: by the end of the study, five people in the UC-II group reported no pain during or after the stepmill protocol, compared with one in the placebo group (p = 0.031). No product-related adverse events were observed.
The Fine Print: Read This Before You Buy
The numbers are encouraging, but they have limits.
- "Doubled" is a before-and-after comparison. The 1.4 to 2.8 minute change is UC-II at day 120 versus its own baseline. The paper reports no significant change in placebo, but this is not the same as a clean head-to-head win on that measure. Some outcomes, such as knee extension at day 90, were also compared only against baseline.
- The sample is small. With 55 people, a few responders can move the averages.
- Industry sponsorship. The study was tied to the maker of UC-II (InterHealth). Sponsorship doesn't invalidate results, but independent replication matters.
- Healthy participants only. The trial did not enroll people with osteoarthritis or injuries. Other research has looked at arthritis, but this study can't speak to it.
- The test is a proxy. Minutes to pain on a stepmill is a useful, standardized measure, but it isn't the same as a better squat, a faster 10K, or a healthier joint. The paper reports function and symptoms, not cartilage changes.
Treat this as an interesting signal from a single trial, not proof that UC-II protects your knees.
Practical Takeaways for Lifters and Runners
The dose: The trial used 40 mg per day. More isn't necessarily better, and this study doesn't support going above that.
The timeline: Be patient. Knee extension was significantly better by day 90, and the pain-onset improvement was reported at day 120. That points to roughly 3 to 4 months of consistent daily use, not a pre-workout effect.
Who it might suit: Healthy, active people with exercise-related knee discomfort and no diagnosed joint disease. That is the population studied.
Who should talk to a professional first: Anyone with persistent pain, swelling, locking, a past injury, or a possible arthritis diagnosis. Supplements don't replace a proper evaluation, and pain at rest is a different problem from the one studied here.
How to read labels:
- Look for the words "undenatured type II collagen" or the UC-II name, with the dose listed in milligrams.
- A label showing 10 g of "hydrolyzed collagen peptides" is a different product and not what this trial tested.
- Be wary of blends that hide the amount of undenatured type II collagen behind a proprietary total.
- The study used the branded UC-II product, so generic products may not match its form or quality.
The Bottom Line
A 40 mg daily dose of undenatured type II collagen was well tolerated and was linked to better knee extension and a longer time before knee pain began in healthy people with exercise-related discomfort. The study was randomized and placebo-controlled, but it was small, sponsored by industry, and based partly on within-group comparisons. If your knees ache during training, UC-II is a reasonable low-dose option to discuss with a clinician. Keep your expectations modest, and keep doing the basics: smart load progression, strength work around the hips and quads, and enough recovery.